Skip to main content

and
  1. Article

    Open Access

    Synergistic effects of Smac mimetic APG-1387 with anti-PD-1 antibody are attributed to increased CD3 + NK1.1 + cell recruitment secondary to induction of cytokines from tumor cells

    Immune checkpoint inhibitors are approved for the treatment of various tumors, but the response rate is not satisfactory in certain malignancies. Inhibitor of apoptosis proteins (IAP) ubiquitin-E3 ligase activ...

    Wentao Pan, Qiuyun Luo, Eric Liang, Mude Shi, Jian Sun in Cancer Cell International (2024)

  2. Article

    Open Access

    Correction: Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trial

    Qian Jiang, Zongru Li, Yazhen Qin, Weiming Li, Na Xu in Journal of Hematology & Oncology (2023)

  3. Article

    Open Access

    Correction: Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trial

    Qian Jiang, Zongru Li, Yazhen Qin, Weiming Li, Na Xu in Journal of Hematology & Oncology (2022)

  4. Article

    Open Access

    Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trial

    BCR-ABL1T315I mutations confer resistance to tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia (CML). Olverembatinib is a new potent BCR-ABL1 TKI with preclinical activity against T315I-mutated CML. I...

    Qian Jiang, Zongru Li, Yazhen Qin, Weiming Li, Na Xu in Journal of Hematology & Oncology (2022)

  5. Article

    Open Access

    Discovery of a novel ALK/ROS1/FAK inhibitor, APG-2449, in preclinical non-small cell lung cancer and ovarian cancer models

    Tyrosine kinase inhibitors (TKIs) are mainstays of cancer treatment. However, their clinical benefits are often constrained by acquired resistance. To overcome such outcomes, we have rationally engineered APG-...

    Douglas D. Fang, Ran Tao, Guangfeng Wang, Yuanbao Li, Kaixiang Zhang in BMC Cancer (2022)

  6. No Access

    Article

    PKCβII phosphorylates ACSL4 to amplify lipid peroxidation to induce ferroptosis

    The accumulation of lipid peroxides is recognized as a determinant of the occurrence of ferroptosis. However, the sensors and amplifying process of lipid peroxidation linked to ferroptosis remain obscure. Here...

    Hai-Liang Zhang, Bing-**n Hu, Zhi-Ling Li, Tian Du, Jia-Lu Shan in Nature Cell Biology (2022)

  7. Article

    Open Access

    Lauren classification combined with HER2 status is a better prognostic factor in Chinese gastric cancer patients

    Lauren-classification and human epidermal growth factor receptor 2 (HER2) status are two important pathological features of gastric cancer patients. The prognostic value of HER2 in gastric cancer remains contr...

    Miaozhen Qiu, Yixin Zhou, **nke Zhang, Zixian Wang, Fang Wang, Jianyong Shao in BMC Cancer (2014)

  8. Article

    Open Access

    An MDM2 antagonist (MI-319) restores p53 functions and increases the life span of orally treated follicular lymphoma bearing animals

    MI-319 is a synthetic small molecule designed to target the MDM2-P53 interaction. It is closely related to MDM2 antagonists MI-219 and Nutlin-3 in terms of the expected working mechanisms. The purpose of this ...

    Ramzi M Mohammad, Jack Wu, Asfar S Azmi, Amro Aboukameel, Angela Sosin in Molecular Cancer (2009)

  9. Article

    Open Access

    AT-101, a small molecule inhibitor of anti-apoptotic Bcl-2 family members, activates the SAPK/JNK pathway and enhances radiation-induced apoptosis

    Gossypol, a naturally occurring polyphenolic compound has been identified as a small molecule inhibitor of anti-apoptotic Bcl-2 family proteins. It induces apoptosis in a wide range of tumor cell lines and enh...

    Shuraila F Zerp, Rianne Stoter, Gitta Kuipers, Dajun Yang in Radiation Oncology (2009)

  10. Article

    Open Access

    Preclinical studies of Apogossypolone: a new nonpeptidic pan small-molecule inhibitor of Bcl-2, Bcl-XL and Mcl-1 proteins in Follicular Small Cleaved Cell Lymphoma model

    Elevated expression of anti-apoptotic Bcl-2 family proteins have been linked to a poor survival rate of patients with Follicular Lymphoma (FL). This prompted us to evaluate a very potent non-peptidic Small-Mol...

    Alan A Arnold, Amro Aboukameel, Jianyong Chen, Dajun Yang in Molecular Cancer (2008)